Company · CIK 0001680048 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MUSTANG BIO, INC. · MBIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2018 PForm 4 → | Dec 7, 4:44 pm EST | Neil HerskowitzDirector | 1,000 | $3.96 | $3,960 | 71,000 | +1.43% | plan? late |
| Nov 20, 2018 PForm 4 → | Dec 18, 4:59 pm EST | Manuel Litchman M.D.President and CEO, Director | 28,000 | $3.71 | $103,927 | 28,000 | — | plan? late |
| Nov 16, 2018 PForm 4 → | Dec 3, 12:47 pm EST | Brian AchenbachVP, Fin. & Corp. Controller | 2,500 | $4.20 | $10,497 | 57,500 | +4.55% | plan? late |
| Nov 2, 2018 PForm 4 → | Nov 5, 8:06 pm EST | Lindsay A Rosenwald M.D.Director | 50,000 | $4.41 | $220,500 | 70,000 | +250% | plan? |
| Jun 14, 2018 AForm 4 → | Dec 7, 4:44 pm EST | Neil HerskowitzDirector | 10,000 | — | — | 70,000 | — | plan? late |
| Jun 14, 2018 AForm 4 → | Nov 13, 6:37 am EST | Adam J. ChillDirector | 13,000 | $5.18 | $15,530 | 63,000 | — | plan? late |
| Feb 2, 2018 AForm 4 → | Dec 3, 12:47 pm EST | Brian AchenbachVP, Fin. & Corp. Controller | 55,000 | — | — | 55,000 | — | plan? late |
| Sep 30, 2016 AForm 4 → | Jun 7, 2017, 5:43 pm EDT | Fortress Biotech, Inc.10% Owner | 1,132,653 | — | — | 10,132,653 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.